Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity - Summary of Activity and Information regarding Outstanding and Exercisable Options (Details)

v3.23.1
Stockholders' Equity - Summary of Activity and Information regarding Outstanding and Exercisable Options (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Equity [Abstract]    
Options Outstanding, Beginning balance 5,797,185  
Options outstanding, granted 811,831  
Options Outstanding, Exercised (46,500)  
Options Outstanding, Cancelled/forfeited (16,888)  
Options Outstanding, Ending balance 6,545,628 5,797,185
Options Outstanding, Options exercisable 5,449,715  
Weighted Average Exercise Price, Beginning balance $ 2.22  
Weighted Average Exercise Price, Granted 4.77  
Weighted average exercise price, exercised 1.81  
Weighted Average Exercise Price, Cancelled/forfeited 1.82  
Weighted Average Exercise Price, Ending balance 2.55 $ 2.22
Weighted Average Exercise Price, Options exercisable $ 2.24  
Weighted Average Remaining Contractual Term in Years 7 years 10 months 6 days 8 years 7 months 2 days
Weighted Average Remaining Contractual Term in Years, Options exercisable 7 years 7 months 2 days  
Aggregate Intrinsic Value $ 9,773,706  
Aggregate Intrinsic Value, Options exercisable $ 8,804,841